
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation
Juan Wang, Yang Yang, Feng Sun, et al.
Pharmacological Research (2022) Vol. 187, pp. 106608-106608
Open Access | Times Cited: 34
Juan Wang, Yang Yang, Feng Sun, et al.
Pharmacological Research (2022) Vol. 187, pp. 106608-106608
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30
Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats
Shengpeng Zhang, Peng Zhu, Jianan Yuan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 28
Shengpeng Zhang, Peng Zhu, Jianan Yuan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 28
Mitochondria in depression: The dysfunction of mitochondrial energy metabolism and quality control systems
Mengruo Jiang, Liyuan Wang, Hui Sheng
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 14
Mengruo Jiang, Liyuan Wang, Hui Sheng
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 14
Insights on post-translational modifications in fatty liver and fibrosis progression
C. Nageswara Raju, Kavitha Sankaranarayanan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167659-167659
Closed Access | Times Cited: 1
C. Nageswara Raju, Kavitha Sankaranarayanan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167659-167659
Closed Access | Times Cited: 1
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 21
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 21
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism
Wei‐Jian Ni, Hong Zhou, Hao Lu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 18
Wei‐Jian Ni, Hong Zhou, Hao Lu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 18
H3K18 lactylation accelerates liver fibrosis progression through facilitating SOX9 transcription
Shujun Wu, Jianhong Li, Yanfei Zhan
Experimental Cell Research (2024) Vol. 440, Iss. 2, pp. 114135-114135
Closed Access | Times Cited: 6
Shujun Wu, Jianhong Li, Yanfei Zhan
Experimental Cell Research (2024) Vol. 440, Iss. 2, pp. 114135-114135
Closed Access | Times Cited: 6
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 5
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 5
Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
Lin Jia, Yang Yang, Feng Sun, et al.
Cellular Signalling (2024) Vol. 115, pp. 111035-111035
Closed Access | Times Cited: 4
Lin Jia, Yang Yang, Feng Sun, et al.
Cellular Signalling (2024) Vol. 115, pp. 111035-111035
Closed Access | Times Cited: 4
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives
Ka Zhang, Yiwen Zhu, Ao-Qi Tang, et al.
Translational Oncology (2025) Vol. 52, pp. 102272-102272
Open Access
Ka Zhang, Yiwen Zhu, Ao-Qi Tang, et al.
Translational Oncology (2025) Vol. 52, pp. 102272-102272
Open Access
Multi-Omics Analysis Links Mitochondrial-Related Genes to Idiopathic Pulmonary Fibrosis and In Vivo Transcriptome Validation
Xiaoxia Li, Qichang Lin, Bingyue Guan, et al.
Translational research (2025)
Closed Access
Xiaoxia Li, Qichang Lin, Bingyue Guan, et al.
Translational research (2025)
Closed Access
PFOS causes lysosomes-regulated mitochondrial fission through TRPML1-VDAC1 and oligomerization of MCU/ATP5J2
Wei Yang, Yu Li, Ruzhen Feng, et al.
Journal of Hazardous Materials (2025) Vol. 489, pp. 137685-137685
Closed Access
Wei Yang, Yu Li, Ruzhen Feng, et al.
Journal of Hazardous Materials (2025) Vol. 489, pp. 137685-137685
Closed Access
Mechanism of mitochondrial dysfunction on placental trophoblastic cells in intrahepatic cholestasis of pregnancy
Xiaomei Huang, Eric C. Liao, Aixing Chen, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Xiaomei Huang, Eric C. Liao, Aixing Chen, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
Mechanistic illustration on lipid-metabolism disorders induced by triclosan exposure from the viewpoint of m6A-RNA epigenetic modification
Shuya Chen, Xuedong Wang, Jin Yan, et al.
The Science of The Total Environment (2023) Vol. 901, pp. 165953-165953
Closed Access | Times Cited: 7
Shuya Chen, Xuedong Wang, Jin Yan, et al.
The Science of The Total Environment (2023) Vol. 901, pp. 165953-165953
Closed Access | Times Cited: 7
Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7
Mitochondrial structure and function: A new direction for the targeted treatment of chronic liver disease with Chinese herbal medicine
Zhihui Yang, Jiahui Wang, Tiejian Zhao, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118461-118461
Closed Access | Times Cited: 2
Zhihui Yang, Jiahui Wang, Tiejian Zhao, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118461-118461
Closed Access | Times Cited: 2
Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2
N-methyladenosine modification in ischemic stroke: Functions, regulation, and therapeutic potential
Fei Han
Heliyon (2024) Vol. 10, Iss. 3, pp. e25192-e25192
Open Access | Times Cited: 1
Fei Han
Heliyon (2024) Vol. 10, Iss. 3, pp. e25192-e25192
Open Access | Times Cited: 1
Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In vitro
Jingxia Du, Tingting Wang, C. L. Xiao, et al.
Current Molecular Medicine (2024) Vol. 24, Iss. 12, pp. 1506-1517
Closed Access | Times Cited: 1
Jingxia Du, Tingting Wang, C. L. Xiao, et al.
Current Molecular Medicine (2024) Vol. 24, Iss. 12, pp. 1506-1517
Closed Access | Times Cited: 1
Hua Zhou, Bing Qing Wang, M. Chen, et al.
Journal of Digestive Diseases (2024) Vol. 25, Iss. 5, pp. 298-309
Closed Access | Times Cited: 1
Voltage-dependent anion channel 1 mediates mitochondrial fission and glucose metabolic reprogramming in response to ionizing radiation
Ying Xie, Xiaochang Liu, Dafei Xie, et al.
The Science of The Total Environment (2024) Vol. 946, pp. 174246-174246
Closed Access | Times Cited: 1
Ying Xie, Xiaochang Liu, Dafei Xie, et al.
The Science of The Total Environment (2024) Vol. 946, pp. 174246-174246
Closed Access | Times Cited: 1
The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
Ziwei Liao, Jing Wang, Mengrou Xu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Ziwei Liao, Jing Wang, Mengrou Xu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1